GLH Golden Leaf Holdings Ltd

Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) (“Golden Leaf” or the “Company”), a pioneering cannabis solutions company and dispensary operator built around the recognized brands of Chalice Farms, announced the launch of the RXO product line containing an ultra-pure pharmaceutical grade, full spectrum version of the popular Rick Simpson cannabis oil extract.

Named after its creator, Rick Simpson oil refers to an unrefined, whole-plant, full-spectrum cannabis oil concentrate. To create Chalice Farm’s RXO product line, Golden Leaf Holdings has partnered with Real Solutions Organization utilizing Essential Innovations patented technology to create full-spectrum extract-focused products available in multiple consumption methods, including concentrated cannabis shatter for dabbing, pre-filled vape cartridges, and liquid concentrate for oral consumption. Golden Leaf has launched the RXO product in Oregon in late December 2019 and expects to launch in Nevada in early 2020.

“The RXO product line offers consumers and patients a highly-potent, uniquely pure extract for safe, dosed consumption. By offering this popular extract via several consumption options, we are able to serve a diverse health-focused audience seeking to maximize their wellness through a variety of methods,” said Jeff Yapp, CEO of Golden Leaf Holdings.

“A truly complete oil is not defined by the use of alcohol or presence of any single compound but by the inclusion of all. Our patented production process provides just that.  The full spectrum oil in RXO products are nature’s perfect balance of ingredients with every compound working in harmony to enhance its therapeutic value. We are very proud to play our part in bringing these quality products to the community,” said Real Solutions Co-Founder and President Matt Steele.  

The extract in the RXO product line is created using a proprietary, organic grain ethanol-based extraction method and equipment. By using this proprietary extraction method and advanced process, RXO products feature a cleaner, more pure cannabis concentrate than other RSO products on the market. This concentration also captures the full range of bioactive compounds including flavonoids, phenols, fatty acids and, most importantly, a variety of terpenes and cannabinoids in their natural acid form. Due to this process, RXO is safe for edible, topical, and smokable delivery methods.

To be added to the distribution list please email ir@goldenxtrx.com with “GLH” in the subject line.  For product photos or samples, qualified media may contact goldenleaf@kcsa.com.

About Golden Leaf HoldingsGolden Leaf Holdings Ltd. is a Canadian company with operations in multiple jurisdictions including Oregon, Nevada, and Canada, with cultivation, production and retail operations built around recognized brands. Golden Leaf distributes its products through its branded Chalice Farms retail dispensaries, as well as through third-party dispensaries. Golden Leaf’s cannabis retail operations and products are designed with the customer in mind, focused on superlative in-store experience and quality products. Visit www.goldenleafholdings.com to learn more.

Media Relations:Anne Donohoe / Nick OpichKCSA Strategic Communicationsadonohoe@kcsa.com / nopich@kcsa.com212-896-1265 / 212-896-1206

Investor Relations:John VargheseExecutive ChairmanGolden Leaf Holdings Ltd.971-371-2685 ir@goldenxtrx.com

Disclaimer: This press release contains “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the Company’s future business operations, the opinions or beliefs of management and future business goals. Generally, forward looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information. These risks include but are not limited to general business, economic and competitive uncertainties, regulatory risks, market risks, risks inherent in manufacturing and retail operations such as unforeseen costs and production shutdowns, difficulties in maintaining brand loyalty, and other risks of the cannabis industry. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward looking information. Forward-looking information is provided herein for the purpose of presenting information about management’s current expectations relating to the future and readers are cautioned that such information may not be appropriate for other purpose. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws. This press release does not constitute an offer of securities for sale in the United States, and such securities may not be offered or sold in the United States absent registration or an exemption from registration or an exemption from registration.